+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inhaled Nitric Oxide Market by Product, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Inhaled Nitric Oxide Market by Product, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Inhaled Nitric Oxide Market by Product, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674960
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Inhaled Nitric Oxide Market grew from USD 821.09 million in 2024 to USD 871.37 million in 2025. It is expected to continue growing at a CAGR of 5.89%, reaching USD 1.15 billion by 2030.

Introducing the Evolving Landscape of Inhaled Nitric Oxide

Inhaled nitric oxide has emerged as a transformative therapeutic gas in critical care and pulmonary medicine, offering precise vasodilatory effects with minimal systemic impact. Its adoption across neonatal, adult, and acute respiratory distress treatment settings underscores its clinical significance. As the medical community seeks refined respiratory support modalities, inhaled nitric oxide stands at the forefront of innovation, enabling practitioners to optimize oxygenation and reduce pulmonary arterial pressure with rapid onset and controllable dosing.

This executive summary distills the most compelling insights on market drivers, regulatory catalysts, and emerging challenges. It navigates the evolving landscape shaped by technological advancements in delivery systems, shifting reimbursement paradigms, and the strategic responses of leading stakeholders. By highlighting the current competitive arena and projecting key inflection points, this summary equips decision-makers with a clear understanding of where value lies and how to capitalize on latent growth opportunities.

As healthcare providers refine care protocols and payers reconsider coverage policies, a detailed examination of industry dynamics becomes indispensable. The following sections explore transformative shifts, tariff influences, segmentation patterns, regional nuances, corporate strategies, and actionable recommendations-laying the groundwork for informed strategic planning and market leadership.

Navigating Transformative Shifts Reshaping Inhaled Nitric Oxide

Recent years have witnessed transformative shifts that are redefining the path of inhaled nitric oxide. Breakthroughs in portable generator technology have enabled precise bedside administration, fostering its expansion beyond intensive care units into ambulatory and homecare settings. Concurrently, regulatory bodies have accelerated approval pathways for novel delivery devices, reducing time-to-market and encouraging sustained innovation across established and emerging manufacturers.

Supply chain resilience has also become a critical focus. Raw material standardization and strategic partnerships with gas producers have improved inventory management, mitigating the risk of shortages during peak demand. Technological integration with digital health platforms now allows real-time monitoring of dosing and patient response, enhancing safety profiles and clinical outcomes. These shifts collectively illustrate a market in flux, where agility and multidisciplinary collaboration drive competitive advantage.

Assessing the 2025 US Tariff Dynamics on Inhaled Nitric Oxide

The imposition of revised tariff structures in the United States during 2025 has introduced a new layer of complexity for inhaled nitric oxide stakeholders. Increased duties on specialized compressors, proprietary generators, and transport vessels have elevated production costs, compelling manufacturers to reassess their supply chain expenditures and pricing strategies. In reaction, many organizations have pivoted toward regional manufacturing hubs or diversified component sourcing to contain cost inflation and preserve margin integrity.

These adjustments have triggered ripple effects across contracting negotiations with healthcare providers. Higher unit costs have intensified discussions around reimbursement rates and volume-based agreements, emphasizing the need for demonstrable value and robust clinical evidence. At the same time, some market participants have formed alliances to share tariff burdens, leveraging combined purchasing power to secure preferential duty treatment. In sum, the 2025 tariff landscape has reaffirmed the importance of strategic agility and cost optimization in maintaining market resilience.

Unveiling Strategic Segmentation Patterns Driving Growth

The product spectrum for inhaled nitric oxide delivery ranges from compact cylinders designed for low-volume use to on-site generator systems catering to high-throughput hospitals and large-scale distribution via cryogenic tankers. Each form factor addresses distinct logistical and clinical requirements, influencing adoption rates across care settings. In critical care units, generators offer continuous dosing control, while cylinders remain the preferred choice for emergency kits and remote facilities lacking fixed infrastructure.

Clinical applications further diversify market demand. In adult pulmonary hypertension, patients with idiopathic and secondary etiologies benefit from inhalation protocols tailored to disease severity. Acute respiratory distress syndrome cases managed with extracorporeal membrane oxygenation and traditional invasive ventilation have spurred specialized delivery interfaces. In neonatal care, premature infants experiencing pulmonary hypertension require finely calibrated dosing through both extracorporeal membrane oxygenation circuits and mechanical ventilators. End-user categories-from ambulatory surgical centers to homecare programs-drive differentiated procurement strategies, while direct tenders, distribution partnerships, and emerging online platforms shape product accessibility and service models.

Mapping Regional Variations Shaping Market Trajectories

Regional dynamics underscore the global heterogeneity of inhaled nitric oxide adoption. In the Americas, strong reimbursement frameworks and established hospital networks have accelerated uptake, particularly in tertiary and quaternary care centers specializing in pulmonary interventions. Meanwhile, infrastructure investments in specialized clinics have broadened the care continuum beyond traditional hospital walls, creating new touchpoints for manufacturers to engage stakeholders.

In Europe, the Middle East & Africa region, regulatory harmonization efforts have streamlined cross-border distribution, although localized reimbursement nuances continue to influence market penetration. Investments in critical care training and telemedicine services have enhanced clinician familiarity with nitric oxide therapies. In the Asia-Pacific, rapid urbanization and expanding healthcare infrastructure have generated substantial demand growth, with emerging markets increasingly prioritizing respiratory care innovation. Strategic partnerships between global suppliers and regional distributors have become essential to navigate complex regulatory environments and optimize market access.

Profiling Leading Innovators and Market Drivers

Leading players in the inhaled nitric oxide arena are leveraging R&D investments and strategic collaborations to sustain competitive differentiation. Established gas producers have expanded their portfolio to include proprietary delivery systems, integrating hardware and consumables for seamless provider experiences. Concurrently, medical device innovators are forging alliances with clinical research organizations to generate robust evidence on long-term outcomes and cost-effectiveness, strengthening their value propositions during reimbursement discussions.

Recent product launches highlight the focus on miniaturization and connectivity, with next-generation generators featuring integrated IoT capabilities for remote monitoring and predictive maintenance. Some market entrants are aligning with digital health platforms, offering end-to-end solutions that encompass dosing algorithms, patient adherence tracking, and data analytics dashboards. These differentiated approaches underscore the importance of ecosystem play, where cross-sector partnerships between device manufacturers, software developers, and healthcare providers catalyze sustainable growth.

Actionable Strategies for Industry Advancement

Industry advancement in inhaled nitric oxide hinges on targeted strategies that balance innovation, access, and cost efficiency. First, stakeholders should diversify production footprints by establishing regional assembly lines or forming joint ventures with local gas suppliers to mitigate tariff impacts and logistic constraints. Second, investing in modular, portable delivery systems will unlock new care settings, particularly in homecare and ambulatory centers, enabling expansion beyond traditional hospital environments.

Third, forging deeper relationships with payers and health technology assessment bodies through collaborative evidence-generation initiatives will strengthen value communication and reimbursement positioning. Fourth, embracing digital health integration-such as cloud-based dosing platforms and predictive analytics for patient monitoring-will enhance safety and drive provider adoption. Lastly, cultivating real-world evidence through post-market surveillance studies and registry partnerships will demonstrate long-term benefits and support formulary inclusion.

Robust Methodology Ensuring Data Integrity

This report synthesizes primary and secondary research methodologies to ensure data integrity and analytical rigor. In-depth interviews with clinicians, procurement specialists, and senior executives provided qualitative insights into clinical adoption patterns, procurement drivers, and unmet needs. Simultaneously, a comprehensive review of regulatory filings, patent databases, and industry publications facilitated quantitative triangulation of market trends and competitive benchmarks.

Data validation incorporated cross-referencing of shipment statistics, financial disclosures, and reimbursement schedules, while iterative stakeholder validation workshops refined key assumptions. Dedicated quality control protocols ensured consistency and accuracy across regional analyses and segmentation breakdowns. This robust methodology delivers a transparent, reproducible foundation for strategic decision-making, equipping readers with confidence in the reported findings.

Concluding Perspectives on Inhaled Nitric Oxide Outlook

Inhaled nitric oxide continues to redefine critical care by offering precision therapy for patients with complex pulmonary conditions. The convergence of technological innovation, evolving regulatory pathways, and shifting reimbursement landscapes has created a dynamic market characterized by both opportunity and complexity. Stakeholders who proactively address tariff challenges, harness segmentation insights, and tailor regional strategies will secure competitive advantage.

Leading companies that invest in digital integration and evidence-generation will differentiate their offerings, while cost optimization through supply chain diversification remains paramount. As healthcare systems worldwide navigate fiscal pressures and demand superior clinical outcomes, the ability to articulate clear value propositions and demonstrate long-term benefits will determine market success. The insights within this summary lay the groundwork for strategic planning, guiding stakeholders toward informed decisions and sustained growth.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product
    • Cylinder
    • Generator
    • Tanker
  • Application
    • Adult Pulmonary Hypertension
      • Idiopathic
      • Secondary
    • Ards
      • Extracorporeal Membrane Oxygenation
      • Invasive Ventilation
    • Neonatal Pulmonary Hypertension
      • Extracorporeal Membrane Oxygenation
      • Mechanical Ventilation
  • End User
    • Ambulatory Surgical Centers
    • Homecare
    • Hospitals
    • Specialty Clinics
  • Distribution Channel
    • Direct Tender
    • Distribution Partner
    • Online
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Mallinckrodt plc
  • Linde plc
  • Air Liquide S.A.
  • Air Products and Chemicals, Inc.
  • Messer SE & Co. KGaA
  • Nippon Sanso Holdings Corporation
  • Bellerophon Therapeutics, Inc.
  • GENERON IGS Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Inhaled Nitric Oxide Market, by Product
8.1. Introduction
8.2. Cylinder
8.3. Generator
8.4. Tanker
9. Inhaled Nitric Oxide Market, by Application
9.1. Introduction
9.2. Adult Pulmonary Hypertension
9.2.1. Idiopathic
9.2.2. Secondary
9.3. Ards
9.3.1. Extracorporeal Membrane Oxygenation
9.3.2. Invasive Ventilation
9.4. Neonatal Pulmonary Hypertension
9.4.1. Extracorporeal Membrane Oxygenation
9.4.2. Mechanical Ventilation
10. Inhaled Nitric Oxide Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Homecare
10.4. Hospitals
10.5. Specialty Clinics
11. Inhaled Nitric Oxide Market, by Distribution Channel
11.1. Introduction
11.2. Direct Tender
11.3. Distribution Partner
11.4. Online
12. Americas Inhaled Nitric Oxide Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Inhaled Nitric Oxide Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Inhaled Nitric Oxide Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Mallinckrodt plc
15.3.2. Linde plc
15.3.3. Air Liquide S.A.
15.3.4. Air Products and Chemicals, Inc.
15.3.5. Messer SE & Co. KGaA
15.3.6. Nippon Sanso Holdings Corporation
15.3.7. Bellerophon Therapeutics, Inc.
15.3.8. GENERON IGS Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. INHALED NITRIC OXIDE MARKET MULTI-CURRENCY
FIGURE 2. INHALED NITRIC OXIDE MARKET MULTI-LANGUAGE
FIGURE 3. INHALED NITRIC OXIDE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. INHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. INHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. INHALED NITRIC OXIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY CYLINDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY GENERATOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY TANKER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY IDIOPATHIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY SECONDARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY INVASIVE VENTILATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY MECHANICAL VENTILATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION PARTNER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 51. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 52. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 53. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 59. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 60. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 94. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 95. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 101. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 102. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 103. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 115. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 116. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 117. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 122. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 123. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 124. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 150. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 151. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 152. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 164. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 165. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 166. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 171. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 172. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 173. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 192. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 193. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 194. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 199. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 200. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 201. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 213. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 214. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 215. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 220. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 221. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 222. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 239. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 242. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 243. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 244. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 249. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 250. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 251. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 256. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 257. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 258. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 284. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 285. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 286. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 289. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 303. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 316. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 317. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY ADULT PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY ARDS, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL PULMONARY HYPERTENSION, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. INHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2024
TABLE 324. INHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Inhaled Nitric Oxide market report include:
  • Mallinckrodt plc
  • Linde plc
  • Air Liquide S.A.
  • Air Products and Chemicals, Inc.
  • Messer SE & Co. KGaA
  • Nippon Sanso Holdings Corporation
  • Bellerophon Therapeutics, Inc.
  • GENERON IGS Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 871.37 Million
Forecasted Market Value ( USD ) by 2030 $ 1150 Million
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Inhaled Nitric Oxide Delivery Systems Market by Application, End User, Technology, Delivery Device Type, Distribution Channel, Mode Of Delivery - Global Forecast to 2030 - Product Image

Inhaled Nitric Oxide Delivery Systems Market by Application, End User, Technology, Delivery Device Type, Distribution Channel, Mode Of Delivery - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Inhaled Nitric Oxide Market Report by Application, and Region 2024-2032 - Product Image

Inhaled Nitric Oxide Market Report by Application, and Region 2024-2032

  • Report
  • 145 Pages
  • Global
From
Inhaled Nitric Oxide Delivery Systems - Global Strategic Business Report - Product Image

Inhaled Nitric Oxide Delivery Systems - Global Strategic Business Report

  • Report
  • 471 Pages
  • Global
From
Inhaled Nitric Oxide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Inhaled Nitric Oxide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Inhaled Nitric Oxide Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Inhaled Nitric Oxide Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From

About the Inhaled Nitric Oxide Delivery System Market

The Oxides market is a sector of the chemical industry that produces and sells oxides, which are compounds of oxygen and other elements. Oxides are used in a variety of applications, including industrial, medical, and agricultural. Oxides are also used in the production of paints, plastics, and other materials. Oxides are produced through a variety of processes, including thermal decomposition, electrolysis, and chemical synthesis. The production of oxides is a complex process that requires specialized equipment and expertise. The Oxides market is highly competitive, with many companies offering a wide range of products. Some of the major players in the market include BASF, Dow Chemical, Evonik Industries, and Solvay. These companies produce a variety of oxides, including aluminum oxide, calcium oxide, and magnesium oxide. Other companies in the market include AkzoNobel, Clariant, and Wacker Chemie. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.